Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen-to-twenty-one-month-old children